Co-Diagnostics, Inc. (CODX)
NASDAQ: CODX · Real-Time Price · USD
0.3560
-0.0190 (-5.07%)
Apr 23, 2025, 4:00 PM EDT - Market closed
Co-Diagnostics Revenue
In the year 2024, Co-Diagnostics had annual revenue of $3.92M, down -42.53%. Co-Diagnostics had revenue of $149.33K in the quarter ending December 31, 2024, a decrease of -95.80%.
Revenue (ttm)
$3.92M
Revenue Growth
-42.53%
P/S Ratio
2.74
Revenue / Employee
$29,660
Employees
132
Market Cap
11.95M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.92M | -2.90M | -42.53% |
| Dec 31, 2023 | 6.81M | -27.41M | -80.09% |
| Dec 31, 2022 | 34.22M | -63.67M | -65.04% |
| Dec 31, 2021 | 97.89M | 23.33M | 31.30% |
| Dec 31, 2020 | 74.55M | 74.34M | 34,579.90% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 410.06B |
| Johnson & Johnson | 89.33B |
| Merck & Co. | 64.17B |
| AbbVie | 56.33B |
| AstraZeneca | 54.07B |
| Novartis AG | 51.72B |
| Eli Lilly and Company | 45.04B |
| Thermo Fisher Scientific | 42.88B |
CODX News
- 27 days ago - Co-Diagnostics, Inc. (CODX) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 27 days ago - Co-Diagnostics, Inc. Reports Full Year 2024 Financial Results - PRNewsWire
- 5 weeks ago - Co-Diagnostics, Inc. Announces Fourth Quarter and Full Year 2024 Earnings Release Date and Webcast - PRNewsWire
- 7 weeks ago - Co-Diagnostics, Inc. and CoSara to Host HPV and Cancer Symposium on International HPV Day 2025 - PRNewsWire
- 2 months ago - Penny Stock Co-Diagnostics Withdraws FDA Application For COVID-19 Test, Plans To Submit Enhanced Version - Benzinga
- 2 months ago - Co-Diagnostics, Inc. Announces Intention to Submit Enhanced Version of COVID-19 Test to FDA for 510(k) Clearance - PRNewsWire
- 3 months ago - Co-Diagnostics, Inc. to Participate at the Nasdaq Live from MarketSite Broadcast at Silicon Slopes 2025 - PRNewsWire
- 4 months ago - Co-Diagnostics, Inc. and CoSara Diagnostics to Inaugurate New Oligo Facility - PRNewsWire